The gap between policy and practice is costing you your most experienced talent. Here's what forward-thinking organisations are doing differently.
Most benefits leaders have menopause policies. Many offer flexible working. Some have added fertility support or women's health webinars to their annual calendar. Yet attrition among women in their 30s, 40s and 50s continues to rise. Exit interviews cite "personal reasons" or "better opportunities elsewhere". The real drivers remain invisible.
Women's health issues don't announce themselves in HR metrics until it's too late. A high performer quietly steps back from a promotion. A senior leader takes intermittent sick days. A mid-career employee resigns without warning. By the time health-related attrition shows up in your data, you've already lost the talent, the institutional knowledge and the business case for keeping them.
Policies signal intent. Consistent, accessible support demonstrates commitment. The organisations losing women aren't the ones without frameworks. They're the ones where implementation varies wildly across teams, where managers avoid difficult conversations and where employees don't trust that disclosing a health issue won't damage their career trajectory.
One manager confidently signposts support and explores adjustments. Another tells an employee to "just push through". One woman receives rapid clinical guidance for endometriosis symptoms. Another waits months for a GP appointment while her performance deteriorates. Tribunals don't penalise organisations for lacking a menopause policy. They penalise them for failing to act consistently when the need arises.
Legal exposure under the Equality Act 2010 already exists. Menopause symptoms can meet the threshold for disability protection when they have substantial, long-term adverse effects. The duty to consider reasonable adjustments applies not only when an employer knows about a condition, but when they ought reasonably to know. Visible symptoms affecting work trigger that duty whether or not formal disclosure has occurred.
Certain life stages carry elevated risk. Fertility treatment, pregnancy complications, menopause and long-term conditions like endometriosis or cardiovascular disease don't strike randomly. They affect predictable cohorts at predictable career stages. Women navigating these journeys without support make calculated decisions about their futures.
Research shows 69% of women report menstrual symptoms negatively affecting their work. One in four women experiencing menopause symptoms consider leaving. One in ten actually do. Those aren't awareness statistics. They're attrition forecasts. When you lose a woman at director level due to unsupported health needs, replacement costs range from 50% to 200% of her salary. Recruitment fees, onboarding time, lost relationships, delayed projects and the productivity gap during ramp-up all compound.
Organisations underestimate the hidden costs. Management time spent interviewing. Team disruption. Client handovers. Institutional knowledge that walks out the door. A senior woman leaving because of unmanaged menopause symptoms doesn't just create a vacancy. She weakens your leadership pipeline exactly when gender balance targets demand you strengthen it.
Early intervention isn't another awareness campaign. It's clinical access before symptoms escalate. It's a woman with suspected PCOS getting testing, diagnosis and treatment guidance within weeks instead of waiting months in the NHS queue. It's someone navigating fertility treatment receiving proactive check-ins that reduce the emotional load and prevent unplanned absence.
Proactive support means employees access specialist clinicians confidentially, outside line management structures. They receive evidence-based guidance tailored to their symptoms and life stage. They get clear next steps without needing to become healthcare navigation experts themselves. When support sits outside the business, it removes the pressure on managers to be clinical experts and gives employees psychological safety to seek help early.
Organisations tracking impact see measurable outcomes. Menopause-related work impairment drops 15% within 90 days. Severe symptoms reduce 58% at 180 days. Absence rates decrease. Confidence improves. Women stay engaged through transitions that would previously have triggered resignations.
The financial question isn't whether proactive women's health support delivers returns. It's whether you can afford the cost you're currently absorbing. Attrition you're not tracking. Presenteeism you're not measuring. Leadership pipeline erosion you're not addressing until quarterly diversity reports highlight the gap.
Voluntary attrition rates among women, particularly at mid-career and senior levels, signal where support fails. Proportion of women returning from parental leave and remaining beyond two years indicates whether transitions are genuinely supported or merely tolerated. Long-term absence trends segmented by gender and age reveal patterns standard benefits don't address.
Organisations that measure impact don't just track policy uptake. They track retention rates before and after implementing specialist support. They monitor absence data with clinical lenses. They ask whether women advance into senior roles at the same rate as men, and whether health-related barriers contribute when they don't.
Supporting women isn't an HR initiative. It's a leadership decision that aligns directly with business resilience. Women control or influence 70% to 80% of household consumer spending. They represent your customer base, your client decision-makers and your market. Organisations that fail to retain women through key life stages lose the perspective needed to serve the markets they operate in.
Leadership accountability means treating women's health as a strategic workforce issue, not a wellbeing programme. It means holding senior leaders responsible for retention metrics segmented by gender. It means equipping managers with clear pathways to specialist support so they're not expected to handle clinical conversations alone. It means measuring whether policies translate into consistent practice across every team.
Boards asking the right questions don't ask whether menopause support exists. They ask whether attrition data shows it's working. They ask what proportion of women experiencing fertility challenges, pregnancy complications or long-term gynaecological conditions feel confident disclosing that to their manager. They ask whether the organisation can demonstrate that support was visible, accessible and effective when needed.
Policies establish frameworks. Clinical support delivers outcomes. The organisations retaining women through critical health transitions are the ones providing confidential access to specialist practitioners who understand the full spectrum of female health across life stages.
Menstruation and gynaecological conditions that affect performance but remain undisclosed. Fertility and family planning journeys that create invisible emotional and logistical burdens. Cardiovascular and bone health risks that develop asymptomatically during peak career years. Perimenopause and menopause transitions that affect cognition, energy and confidence. These aren't edge cases requiring bespoke interventions. They're common, predictable challenges that specialist clinical support addresses before they escalate.
Benefits leaders evaluating current provision should ask whether employees know where to go for help. Whether managers feel confident signposting support without needing clinical expertise. Whether the support available is timely, specialist and demonstrably effective. Whether the organisation can evidence that health needs across different life stages receive consistent attention.
Why does women's health support matter for talent retention?
Unaddressed health needs drive attrition at exactly the career stages where organisations most need to retain women. Fertility challenges, gynaecological conditions, menopause symptoms and long-term health issues affect performance, confidence and career decisions. When support arrives too late or not at all, experienced women disengage or leave. Proactive clinical access keeps women in work through transitions that would otherwise trigger resignations.
What makes women's health support legally defensible?
Under the Equality Act 2010, menopause symptoms and other long-term health conditions can constitute disability when they have substantial adverse effects on day-to-day activities. Employers have a duty to consider reasonable adjustments not only when formally notified but when they ought reasonably to know about health issues affecting work. Tribunals assess whether support was accessible, whether managers responded appropriately and whether adjustments were considered. Demonstrable clinical pathways and consistent practice strengthen legal defensibility.
How do you measure whether women's health support is working?
Voluntary attrition rates among women at mid-career and senior levels indicate whether support prevents health-driven resignations. Return-to-work rates following parental leave show whether transitions are genuinely supported. Long-term absence trends segmented by gender and age reveal patterns that standard benefits miss. Clinical outcomes including symptom severity reduction, work impairment scores and confidence measures provide evidence of health improvement. Organisations tracking these metrics can quantify impact and build business cases for continued investment.
What distinguishes proactive women's health support from reactive benefits?
Reactive benefits engage after problems escalate. EAPs activate during crisis. Occupational Health intervenes post-absence. Proactive support provides clinical access before symptoms become unmanageable. Women receive specialist guidance early, reducing the likelihood of long-term absence or resignation. Early intervention costs less than managing attrition, recruitment and productivity loss from replacing experienced talent.
Is women's health support only relevant for organisations with female-majority workforces?
Women's health affects every organisation regardless of gender balance. Even in male-dominated sectors, women occupy critical roles where their retention directly impacts business continuity. Leadership pipeline health, client relationships, institutional knowledge and market understanding all depend on retaining experienced women through key life stages. Organisations competing for talent need credible, specialist support that differentiates their employee value proposition.